Endo

Pharmalot By Damian Garde

Pharmalittle: Biogen sells stake in biosimilars business for $2.3 billion; Lilly gives up on a lucrative idea

First Opinion By Jennifer Goldsack and Soujanya (Chinni) Pulluru

Break the stranglehold of the doctor-patient visit on health care innovation

First Opinion By Vincent Casingal

Maximizing kidney transplant equity means minimizing geography

The Readout LOUD By Adam Feuerstein, Damian Garde and Meg Tirrell

‘There’s no free lunch with drugs’: Janet Woodcock talks Covid monoclonal antibodies and pediatric vaccines

Health By Elizabeth Cooney

In ‘chemo brain,’ researchers see clues to unravel long Covid’s brain fog

Biotech By Adam Feuerstein, Damian Garde and Matthew Herper

‘Nowhere to hide’: As biotech stocks plummet, an industry is being reshaped by the fallout

Biotech By Damian Garde and Adam Feuerstein

Biogen sells stake in Samsung venture for $2.3 billion

Pharmalot By Ed Silverman

U.S. International Trade Commission will investigate AbbVie claims that rival stole secrets